Vertical Integration: A Playbook for Independent IPAs

What is payer-provider vertical integration, and why now?

Horizontal consolidation — hospitals buying hospitals, groups merging with groups — has reshaped health care for decades. Vertical integration is different and, for networks, more consequential: it stitches together the insurer, the medical group, the ancillary services, and the data under one balance sheet. Optum is the archetype, but it is not alone. CVS Health owns Aetna and acquired Oak Street Health and Signify Health; Humana operates CenterWell primary care and home health; regional Blues and provider-sponsored plans are building or buying delivery arms of their own.

The 'why now' is Medicare Advantage economics. With MA now covering more than half of eligible Medicare beneficiaries, a plan that also owns the provider can capture the medical-loss dollar, control coding and documentation, steer referrals to owned assets, and book profit at the delivery layer that never appears in plan-level margins. MedPAC has flagged exactly this dynamic, noting that vertical integration makes plan profitability harder to interpret and that a growing share of the largest insurers' medical spending now flows to organizations under the same corporate parent.

For an independent group, the takeaway is not to panic but to understand the game being played. When your largest payer also owns a competing medical group, every network decision — who is in-network, how directories steer patients, which providers get favorable tiering — is now made by an entity with a direct stake in your patients moving elsewhere. That conflict is the backdrop for every contract you sign.

How does consolidation reshape the provider network?

Integrated payers reshape networks through several levers at once. They narrow networks around owned or tightly aligned providers, arguing that a smaller, high-performing panel improves quality and cost. Optum has publicly signaled a shift toward employed or contractually dedicated physicians and away from loosely affiliated ones, with networks expected to tighten further. For an independent group, that can mean quiet removal from a preferred tier, or exclusion from a new narrow-network product entirely.

They also steer. Directory placement, referral pathways, care-management outreach, and digital front doors can all be tuned to route members toward owned assets. And they hold a data advantage: an integrated entity sees claims, clinical, and utilization data across the market that an independent IPA cannot match, which sharpens both its negotiating position and its ability to target acquisitions. Independent groups should assume this asymmetry exists and plan around it, not wish it away.

The pricing consequences are documented. Health Affairs research finds that hospital- and private-equity-affiliated specialty physicians negotiate materially higher commercial prices than independent physicians — evidence that integration shifts leverage, not just logos. If your position is eroding or your build has stalled, an honest diagnostic beats another vendor deck.

Where does an independent IPA actually hold leverage?

Independence survives on things integration cannot easily replicate. The first is local density: if your group is where a meaningful share of a county's seniors already receive care, no plan can build an adequate network in that market without you. Network adequacy rules give geography teeth — a plan that cannot meet CMS time-and-distance standards without your physicians has to deal with you. Knowing your own adequacy footprint, and the plan's, is leverage you can quantify.

The second is performance. In a Stars- and quality-driven program, a group that reliably delivers strong HEDIS results, tight medical-cost management, and high patient retention is an asset a rational plan pays to keep. The third is physician loyalty and speed: independents decide, adopt tools, and align incentives faster than a corporate hierarchy, and physicians who value autonomy stay with a well-run group. Our note on IPA risk readiness walks through how to measure whether your group can actually carry that weight.

The fourth source of leverage is optionality. A group that is credible with multiple plans — and credible as a risk-bearing entity — is never captive to one payer's roadmap. The moment a plan believes you have nowhere else to go, your rates and terms deteriorate. Cultivating genuine alternatives, even ones you never exercise, is what keeps a negotiation honest.

How should independents structure contracts to keep leverage?

Contract structure is where strategy becomes durable. Start with rates you can defend: benchmark every fee schedule against Medicare and regional norms so you know precisely what you are being offered and what comparable groups command. Our approach to fee-schedule benchmarking treats this as ongoing intelligence, not a once-a-year event. A rate you cannot benchmark is a rate you cannot negotiate.

Then protect the relationship itself. Watch for anti-steering and anti-tiering provisions that let a plan quietly route volume to owned competitors, and negotiate for transparency in directory and tiering placement. Insist on reasonable term and termination protections, notice periods, and continuity-of-care commitments so you are not dropped mid-cycle. Secure data rights to your own attributed-member and quality data, because integrated plans will otherwise control the very information you need to prove your value. And scrutinize amendment mechanics: many rate erosions arrive not as renegotiations but as unilateral amendments buried in a notice, a pattern we cover in contract amendment management.

Finally, read every clause against the question, does this make me easier to displace? Exclusivity that locks you to a single integrated payer, most-favored-nation terms, and open-ended assignment or acquisition clauses all erode independence. The anatomy of a provider contract is where these terms live, and where a disciplined group wins or loses years of leverage in a single signature. When the stakes are this high, having an experienced guide review the language before you sign is not overhead — it is our services at their most valuable.

Build the infrastructure to bear risk

The most durable defense against being acquired is becoming an organization that can do what integrated players do — manage risk — while staying independent. That means real value-based-care infrastructure: accurate risk adjustment and documentation, care management for high-need patients, referral management that keeps appropriate care in-network, and analytics that let you see your population the way a payer does. Groups that master these capabilities capture the shared savings and capitated margin that would otherwise accrue to an owner.

This is a build, and it is not trivial. The requirements for a value-based network — infrastructure, contracts, and the specialist relationships that make total-cost-of-care management possible — are demanding, and many groups underestimate them. But they are also the price of admission to the only game that pays independents like owners. The question is not whether to build risk capability, but how fast, and whether to build, partner, or buy the pieces you lack.

Build, partner, or sell — choosing your path

Every independent group eventually faces the strategic fork. Building risk and network capability in-house preserves the most autonomy and the most upside, but demands capital, talent, and time. Partnering — with an enablement company, a clinically integrated network, or a like-minded IPA — can supply infrastructure and negotiating scale while keeping local governance intact, provided the terms do not simply recreate the dependence you were trying to escape. Selling to a payer, health system, or private-equity platform can be the right answer when succession, capital needs, or market dynamics make independence untenable — but it should be a decision made from strength, not desperation.

The wrong way to choose is to drift. Groups that delay until a payer narrows them out or a competitor consolidates the market lose the leverage that would have made any of these paths favorable. The build-versus-outsource decision deserves a deliberate, numbers-driven analysis long before it becomes urgent. Whatever path you choose, choose it while you still hold cards.

Your next move

The consolidation wave is real, and the data — from the AMA, MedPAC, KFF, and health-services researchers — leaves no doubt about its direction. But direction is not destiny. Independent IPAs and physician groups that quantify their adequacy footprint, harden their contracts, and build genuine risk capability are not just surviving this environment; they are the partners integrated plans still need and the acquirers still court. Independence, played well, is leverage, and Kearny Street Management does exactly this work with independent groups: mapping where you hold the cards, pressure-testing the terms that quietly give them away, and building the network and risk infrastructure that keep you at the table. If consolidation is reshaping your market faster than your strategy, talk to our team — the plan starts with an honest look at where your leverage actually lives.